Showing results (1-10 of 202) with videos related to
Sort By:
Pageof 21
Expert Review of Clinical Immunology|May 19, 2010
Dendritic cell-based therapy in Type 1 diabetes mellitusBrett Phillips, Nick Giannoukakis, Massimo TruccoPediatric Diabetes|June 11, 2008
Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyondNick Giannoukakis, Brett Phillips, Massimo TruccoClinical & Developmental Immunology|July 26, 2011
Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Brett Phillips, Massimo Trucco, Nick GiannoukakisContributions to Nephrology|April 9, 2008
Renal diseases as targets of gene therapyBrett Phillips, Nick Giannoukakis, Massimo TruccoDiabetes Care|June 18, 2011
Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patientsNick Giannoukakis, Brett Phillips, David Finegold, et al.Biotechniques|July 18, 2003
Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospectsNick Giannoukakis, Massimo TruccoCurrent Opinion in Molecular Therapeutics|October 27, 2005
Gene therapy for type 1 diabetes: a proposal to move to the next levelNick Giannoukakis, Massimo TruccoPediatric Diabetes|February 6, 2015
Cellular therapies based on stem cells and their insulin-producing surrogates: a 2015 reality checkNick Giannoukakis, Massimo TruccoCurrent Opinion in Endocrinology, Diabetes, and Obesity|July 5, 2012
A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitusNick Giannoukakis, Massimo TruccoImmunotherapy|November 15, 2012
Dendritic cell therapy for Type 1 diabetes suppressionNick Giannoukakis, Massimo TruccoPageof 21